Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Cash & Equivalents (2018 - 2026)

Alector's (ALEC) quarterly Cash & Equivalents came in at $59.9 million in Q2 2026, up 33.83% year-over-year from $44.8 million in Q2 2025, and down 22.15% quarter-over-quarter from $77.0 million in Q1 2026.

Analysis

Alector (ALEC) Cash & Equivalents (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Cash & Equivalents for 9 consecutive years, with $59.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash & Equivalents rose 33.83% year-over-year to $59.9 million in Q2 2026; TTM through Jun 2026 was $59.9 million, a 33.83% increase from a year earlier, with the FY2025 full-year figure at $65.8 million, up 99.27% from the prior year.
  • Cash & Equivalents was $59.9 million for Q2 2026 at Alector, down from $77.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $454.6 million in Q1 2022 and troughed at $33.0 million in Q4 2024.
  • A 5-year average of $112.3 million and a median of $75.5 million in 2023 frame the typical range for Cash & Equivalents.
  • The widest YoY moves for Cash & Equivalents: up 310.67% in 2022, down 64.33% in 2022.
  • Over 5 years, Cash & Equivalents stood at $154.3 million in 2022, then tumbled by 51.69% to $74.6 million in 2023, then slumped by 55.71% to $33.0 million in 2024, then surged by 99.27% to $65.8 million in 2025, then dropped by 8.95% to $59.9 million in 2026.
  • The last three Cash & Equivalents figures came in at $59.9 million (Q2 2026), $77.0 million (Q1 2026), and $65.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 6.14 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 2.46 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 3.58 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 1.72 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 1.71 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 1.29 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 544.80 Mn
10 Alector 274.68 Mn 101.88 Mn - 59.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.92 Mn
Mar 31, 2026 76.96 Mn
Dec 31, 2025 65.80 Mn
Sep 30, 2025 76.50 Mn
Jun 30, 2025 44.77 Mn
Mar 31, 2025 37.97 Mn
Dec 31, 2024 33.02 Mn
Sep 30, 2024 37.16 Mn
Jun 30, 2024 47.55 Mn
Mar 31, 2024 72.55 Mn
Dec 31, 2023 74.56 Mn
Sep 30, 2023 101.96 Mn
Jun 30, 2023 131.54 Mn
Mar 31, 2023 195.56 Mn
Dec 31, 2022 154.32 Mn
Sep 30, 2022 184.23 Mn
Jun 30, 2022 172.27 Mn
Mar 31, 2022 454.62 Mn
Dec 31, 2021 329.15 Mn
Sep 30, 2021 516.53 Mn